2023 - Research.com Medicine in United Kingdom Leader Award
2022 - Research.com Best Scientist Award
2010 - Fellow of the Royal Society, United Kingdom
2005 - Member of Academia Europaea
2003 - Member of the National Academy of Medicine (NAM)
His main research concerns Psychosis, Psychiatry, Schizophrenia, Neuroscience and Bipolar disorder. His study looks at the relationship between Psychosis and topics such as Odds ratio, which overlap with Case-control study and Genetics. His Psychiatry research is multidisciplinary, incorporating perspectives in Incidence, Epidemiology, Clinical psychology, Pediatrics and Risk factor.
His Incidence research includes themes of Demography and Odds. His Schizophrenia study incorporates themes from Internal medicine, Functional magnetic resonance imaging, Ethnic group and Audiology. Robin M. Murray combines subjects such as Endocrinology and Cardiology with his study of Internal medicine.
His primary areas of investigation include Psychiatry, Psychosis, Schizophrenia, Clinical psychology and Schizophrenia. His research in Psychiatry intersects with topics in Ethnic group, Epidemiology and Risk factor. The study incorporates disciplines such as Young adult, Internal medicine, First episode and Cognition, Neuroscience in addition to Psychosis.
His Internal medicine study frequently draws connections between adjacent fields such as Endocrinology. His study in Neuroscience focuses on Functional magnetic resonance imaging in particular. His study in Schizophrenia is interdisciplinary in nature, drawing from both Audiology, Etiology, Bipolar disorder, Age of onset and Pediatrics.
Robin M. Murray focuses on Psychosis, Schizophrenia, Psychiatry, Clinical psychology and First episode psychosis. Robin M. Murray interconnects Young adult, Internal medicine, First episode, Cognition and Ethnic group in the investigation of issues within Psychosis. Robin M. Murray studied Schizophrenia and Bipolar disorder that intersect with Major depressive disorder and Genetics.
His Psychiatry research incorporates themes from Odds ratio and Epidemiology. His research integrates issues of Polygenic risk score and Jumping to conclusions in his study of Clinical psychology. Robin M. Murray has included themes like Injury prevention and Case-control study in his Cannabis study.
Robin M. Murray mainly investigates Psychosis, Schizophrenia, Psychiatry, Young adult and Internal medicine. Robin M. Murray has researched Psychosis in several fields, including First episode, Odds ratio, Case-control study and Clinical psychology. His Schizophrenia research is multidisciplinary, incorporating elements of Bipolar disorder, Genome-wide association study, Ethnic group and Disease.
The Psychiatry study combines topics in areas such as Suicide prevention, Logistic regression and Epidemiology. His Young adult research is multidisciplinary, relying on both Cross-sectional study, dup, Pediatrics and Retrospective cohort study. His Internal medicine research includes elements of Placebo and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Aiden Corvin;James T. R. Walters.
Meta-Analysis of Regional Brain Volumes in Schizophrenia
Ian C. Wright;Sophia Rabe-Hesketh;Peter W.R. Woodruff;Anthony S. David.
American Journal of Psychiatry (2000)
Large recurrent microdeletions associated with schizophrenia
Hreinn Stefansson;Dan Rujescu;Sven Cichon;Olli P. H. Pietilainen.
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
Louise Arseneault;Mary Cannon;Richie Poulton;Robin Murray.
Common variants conferring risk of schizophrenia
Hreinn Stefansson;Hreinn Stefansson;Roel A. Ophoff;Roel A. Ophoff;Roel A. Ophoff;Stacy Steinberg;Stacy Steinberg;Ole A. Andreassen.
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.
Avshalom Caspi;Terrie E. Moffitt;Terrie E. Moffitt;Mary Cannon;Mary Cannon;Joseph McClay.
Biological Psychiatry (2005)
CHILD DEVELOPMENTAL RISK-FACTORS FOR ADULT SCHIZOPHRENIA IN THE BRITISH 1946 BIRTH COHORT
P Jones;B Rodgers;R Murray;M Marmot.
The Lancet (1994)
Obstetric Complications and Schizophrenia: Historical and Meta-Analytic Review
Mary Cannon;Peter B. Jones;Robin M. Murray.
American Journal of Psychiatry (2002)
Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)
Peter B. Jones;Thomas R. E. Barnes;Linda Davies;Graham Dunn.
Archives of General Psychiatry (2006)
Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study.
Richie Poulton;Avshalom Caspi;Terrie E. Moffitt;Mary Cannon.
Archives of General Psychiatry (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: